Duration of HCV infection as a predictor of nonresponse to interferon

被引:11
作者
Craxi, A
DiMarco, V
Camma, C
Almasio, P
Magrin, S
机构
[1] UNIV PALERMO,CATTEDRA MED INTERNA,I-90133 PALERMO,ITALY
[2] CNR,ISMEDA,PALERMO,ITALY
[3] OSPED V CERVELLO,DIV MED,PALERMO,ITALY
关键词
hepatitis C; interferon-alpha; duration of infection; treatment outcome;
D O I
10.1007/BF02087881
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Duration of hepatitis C virus (HCV) infection is a key feature in determining responsiveness to interferon (IFN). Studies assessing its value as a predictive factor in chronic HCV infection show that a long duration of infection reduces the likelihood of a sustained response to IFN (defined as ALT normalization and clearance of serum HCV-RNA). The effect of HCV infection duration is independent of the presence of cirrhosis and level of HCV viremia. Meta-analysis of IFN trials in acute HCV infection shows an obvious effect of the drug on long-term ALT normalization and HCV-RNA clearance. Treatment of HCV infection during the acute or early chronic phase could therefore maximize therapeutic effectiveness.
引用
收藏
页码:S86 / S92
页数:7
相关论文
共 63 条
[41]   HEPATITIS-C VIRUS SEROTYPE-II RESPONDS MORE FAVORABLY TO INTERFERON-ALPHA THERAPY [J].
ORITO, E ;
MIZOKAMI, M ;
MIZOGUCHI, N ;
OHBA, KI ;
TOHNAI, M ;
YAMANAKA, H ;
OGURI, T ;
HIRASHIMA, N ;
KOIDE, T ;
KANO, H ;
TSUKIYAMAKOHARA, K ;
KOHARA, M ;
LAU, JYN .
JOURNAL OF HEPATOLOGY, 1994, 21 (01) :130-132
[42]  
ORITO E, 1994, J MED VIROL, V44, P410, DOI 10.1002/jmv.1890440418
[43]  
PAGLIARO L, 1994, HEPATOLOGY, V19, P820, DOI 10.1002/hep.1840190404
[44]   THE TREATMENT OF ACUTE POSTTRANSFUSION HEPATITIS-C WITH RECOMBINANT INTERFERON-ALPHA [J].
PALMOVIC, D ;
KURELAC, I ;
CRNJAKOVICPALMOVIC, J .
INFECTION, 1994, 22 (03) :222-223
[45]   RESPONSE RELATED FACTORS IN RECOMBINANT INTERFERON-ALFA-2B TREATMENT OF CHRONIC HEPATITIS-C [J].
PEREZ, R ;
PRAVIA, R ;
LINARES, A ;
RODRIGUEZ, M ;
LOMBRANA, JLS ;
SUAREZ, A ;
RIESTRA, S ;
NAVASCUES, CA ;
RODRIGO, L .
GUT, 1993, 34 (02) :S139-S140
[46]   THE CHANGING RELATIVE PREVALENCE OF HEPATITIS-C VIRUS GENOTYPES - EVIDENCE IN HEMODIALYZED PATIENTS AND KIDNEY RECIPIENTS [J].
POL, S ;
THIERS, V ;
NOUSBAUM, JB ;
LEGENDRE, C ;
BERTHELOT, P ;
KREIS, H ;
BRECHOT, C .
GASTROENTEROLOGY, 1995, 108 (02) :581-583
[47]   SEQUENTIAL CHANGE OF THE HYPERVARIABLE REGION OF THE HEPATITIS-C VIRUS GENOME IN ACUTE INFECTION [J].
SAKAMOTO, N ;
ENOMOTO, N ;
KUROSAKI, M ;
MARUMO, F ;
SATO, C .
JOURNAL OF MEDICAL VIROLOGY, 1994, 42 (01) :103-108
[48]   FACTORS PREDICTIVE OF THE RESPONSE TO INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-C [J].
SERFATY, L ;
GIRAL, P ;
LORIA, A ;
ANDREANI, T ;
LEGENDRE, C ;
POUPON, R .
JOURNAL OF HEPATOLOGY, 1994, 21 (01) :12-17
[49]   HISTOLOGICALLY ADVANCED CHRONIC HEPATITIS-C TREATED WITH RECOMBINANT ALPHA-INTERFERON - A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND CROSS-OVER STUDY [J].
SIECK, JO ;
ELLIS, ME ;
ALFURAYH, O ;
ALI, MA ;
ALI, HA ;
AYUB, A ;
ALFADDA, M ;
ZAFAR, M ;
HALIM, M ;
BERNVIL, SS ;
SAOUR, J ;
ALHOKAIL, A ;
ABATE, ML .
JOURNAL OF HEPATOLOGY, 1993, 19 (03) :418-423
[50]  
SIMMONDS P, 1995, HEPATOLOGY, V21, P570, DOI 10.1002/hep.1840210243